Covid Vaccination: Key Issues Before Indian Government

Covid Vaccination: Key Issues Before Indian Government

The coronavirus numbers in India crossed the 96-Lakh mark on Saturday while Prime Minister Modi on December 4 announced that the country could expect a Covid vaccine within a few weeks.

The statement raises many questions for the country’s healthcare system. According to global vaccine procurement analysis by Duke University, India has bought 1.6 billion vaccine doses approximately making it the largest vaccine buyer.

The study further elaborates that out of the 1.6 billion doses, 500 million are of the Oxford vaccine, 1 billion are for US Novavax and 100 million are of the Russian Sputnik V.

If we go by estimates, vaccine by Oxford University will reportedly be priced around Rs 1000, according to manufacturer Serum’s CEO Adar Poonawalla. Novavax Vaccine ($16/dose) is also expected be priced around Rs 1000 while Sputnik V (Less $20/dose) is expected to be a little more expensive and can cost around Rs 1400.
Oxford — 500 million (50 cr) doses ✖ Rs 1000 = Rs 50,000 crore

Novavax — One billion (100 cr) doses ✖ Rs 1120 = Rs 1 lakh crore

Sputnik V — 100 million (10 cr) ✖ Rs 1400 = Rs 14,000 crore

Total = Rs 1,64,000 crore

THIS WILL COVER ONLY 60 PERCENT OF INDIAN POPULATION

(*This is an approximation of the cost based on reports from RDIF, Oxford University and US govt’s Operation Warp Speed)

If we go by numbers, the approximate cost of the vaccine will be around Rs 1,64,000 crore.

--

--

Digital and Mobile platform for discovering and sharing news on the go

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
India Ahead News

Digital and Mobile platform for discovering and sharing news on the go